About us
Chongde Seeks Truth and Achieves Customers
Company Profile
Innovative driven new drug non clinical research and development full industry chain characteristic service platform

Taichu Group was founded in October 2020 in the Life Blue Bay area of Lingang New Area. It is committed to providing global pharmaceutical companies with services such as non clinical drug evaluation (CRO), antibody drug construction and production (CRO/CDMO), chemical drug formulation research and production (CMC/CDMO), small nucleic acid development, pilot and commercial OEM production (CRO/CDMO/MAH).
The group has established a GLP/GMP quality system that meets international standards, and has a unique technical system at the international advanced level.

Overall layout
  • The main body of the company is located in the Lingang New Area of Shanghai, with a total area of 26200m ² Service facilities for
  • The antibody research and production base is located in BioBay, Suzhou, with an area of 8000m ² GMP factory facilities and laboratories
Corporate culture
Group structure
Investor Relations

As of August 2022, Taichu Biotechnology has completed the A-round financing, with a total financing amount of nearly 400 million yuan.

This round of financing is led by IDG Capital and recognized by well-known investment institutions in the industry.